1. Home
  2. CTRE vs KRYS Comparison

CTRE vs KRYS Comparison

Compare CTRE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$38.19

Market Cap

9.0B

Sector

Real Estate

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$276.47

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
KRYS
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
7.8B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
CTRE
KRYS
Price
$38.19
$276.47
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$42.40
$297.60
AVG Volume (30 Days)
1.9M
225.0K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
3.59%
N/A
EPS Growth
96.25
128.00
EPS
1.57
6.84
Revenue
$476,393,000.00
$389,130,000.00
Revenue This Year
$5.97
$38.74
Revenue Next Year
$13.39
$32.53
P/E Ratio
$23.62
$40.09
Revenue Growth
60.79
33.94
52 Week Low
$27.27
$123.03
52 Week High
$41.72
$298.30

Technical Indicators

Market Signals
Indicator
CTRE
KRYS
Relative Strength Index (RSI) 47.38 59.92
Support Level $35.57 $254.53
Resistance Level $38.27 $297.14
Average True Range (ATR) 0.92 7.54
MACD -0.05 1.65
Stochastic Oscillator 42.77 86.30

Price Performance

Historical Comparison
CTRE
KRYS

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: